These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 31176362)

  • 1. Facilitating validation of prediction models: a comparison of manual and semi-automated validation using registry-based data of breast cancer patients in the Netherlands.
    van Steenbeek CD; van Maaren MC; Siesling S; Witteveen A; Verbeek XAAM; Koffijberg H
    BMC Med Res Methodol; 2019 Jun; 19(1):117. PubMed ID: 31176362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the online prediction model CancerMath in the Dutch breast cancer population.
    Hoveling LA; van Maaren MC; Hueting T; Strobbe LJA; Hendriks MP; Sonke GS; Siesling S
    Breast Cancer Res Treat; 2019 Dec; 178(3):665-681. PubMed ID: 31471837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the CancerMath prognostic tool for breast cancer in Southeast Asia.
    Miao H; Hartman M; Verkooijen HM; Taib NA; Wong HS; Subramaniam S; Yip CH; Tan EY; Chan P; Lee SC; Bhoo-Pathy N
    BMC Cancer; 2016 Oct; 16(1):820. PubMed ID: 27769212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Independent validation of the PREDICT breast cancer prognosis prediction tool in 45,789 patients using Scottish Cancer Registry data.
    Gray E; Marti J; Brewster DH; Wyatt JC; Hall PS;
    Br J Cancer; 2018 Oct; 119(7):808-814. PubMed ID: 30220705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calibration and discriminatory accuracy of prognosis calculation for breast cancer with the online Adjuvant! program: a hospital-based retrospective cohort study.
    Mook S; Schmidt MK; Rutgers EJ; van de Velde AO; Visser O; Rutgers SM; Armstrong N; van't Veer LJ; Ravdin PM
    Lancet Oncol; 2009 Nov; 10(11):1070-6. PubMed ID: 19801202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation and update of a lymph node metastasis prediction model for breast cancer.
    Qiu SQ; Aarnink M; van Maaren MC; Dorrius MD; Bhattacharya A; Veltman J; Klazen CAH; Korte JH; Estourgie SH; Ott P; Kelder W; Zeng HC; Koffijberg H; Zhang GJ; van Dam GM; Siesling S
    Eur J Surg Oncol; 2018 May; 44(5):700-707. PubMed ID: 29449047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and External Validation of Prediction Models for 10-Year Survival of Invasive Breast Cancer. Comparison with PREDICT and CancerMath.
    Karapanagiotis S; Pharoah PDP; Jackson CH; Newcombe PJ
    Clin Cancer Res; 2018 May; 24(9):2110-2115. PubMed ID: 29444929
    [No Abstract]   [Full Text] [Related]  

  • 8. Prognosis in moderate and severe traumatic brain injury: external validation of the IMPACT models and the role of extracranial injuries.
    Lingsma H; Andriessen TM; Haitsema I; Horn J; van der Naalt J; Franschman G; Maas AI; Vos PE; Steyerberg EW
    J Trauma Acute Care Surg; 2013 Feb; 74(2):639-46. PubMed ID: 23354263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External Validation and Optimization of the SPRING Model for Prediction of Survival After Surgical Treatment of Bone Metastases of the Extremities.
    Sørensen MS; Gerds TA; Hindsø K; Petersen MM
    Clin Orthop Relat Res; 2018 Aug; 476(8):1591-1599. PubMed ID: 30020148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting the risk of locoregional recurrence after early breast cancer: an external validation of the Dutch INFLUENCE-nomogram with clinical cancer registry data from Germany.
    Voelkel V; Draeger T; Groothuis-Oudshoorn CGM; de Munck L; Hueting T; Gerken M; Klinkhammer-Schalke M; Lavric M; Siesling S
    J Cancer Res Clin Oncol; 2019 Jul; 145(7):1823-1833. PubMed ID: 30927074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prediction model for underestimation of invasive breast cancer after a biopsy diagnosis of ductal carcinoma in situ: based on 2892 biopsies and 589 invasive cancers.
    Meurs CJC; van Rosmalen J; Menke-Pluijmers MBE; Ter Braak BPM; de Munck L; Siesling S; Westenend PJ
    Br J Cancer; 2018 Oct; 119(9):1155-1162. PubMed ID: 30327564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of a prediction model for long-term outcome of aphasia after stroke.
    Nouwens F; Visch-Brink EG; El Hachioui H; Lingsma HF; van de Sandt-Koenderman MWME; Dippel DWJ; Koudstaal PJ; de Lau LML
    BMC Neurol; 2018 Oct; 18(1):170. PubMed ID: 30322381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of Prostate Cancer: External Validation of the ERSPC Risk Calculator in a Contemporary Dutch Clinical Cohort.
    Gayet M; Mannaerts CK; Nieboer D; Beerlage HP; Wijkstra H; Mulders PFA; Roobol MJ
    Eur Urol Focus; 2018 Mar; 4(2):228-234. PubMed ID: 28753781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk prediction models of breast cancer: a systematic review of model performances.
    Anothaisintawee T; Teerawattananon Y; Wiratkapun C; Kasamesup V; Thakkinstian A
    Breast Cancer Res Treat; 2012 May; 133(1):1-10. PubMed ID: 22076477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semi-automated and fully automated mammographic density measurement and breast cancer risk prediction.
    Llobet R; Pollán M; Antón J; Miranda-García J; Casals M; Martínez I; Ruiz-Perales F; Pérez-Gómez B; Salas-Trejo D; Pérez-Cortés JC
    Comput Methods Programs Biomed; 2014 Sep; 116(2):105-15. PubMed ID: 24636804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. External Validation of Prediction Models for Pneumonia in Primary Care Patients with Lower Respiratory Tract Infection: An Individual Patient Data Meta-Analysis.
    Schierenberg A; Minnaard MC; Hopstaken RM; van de Pol AC; Broekhuizen BD; de Wit NJ; Reitsma JB; van Vugt SF; Graffelman AW; Melbye H; Rainer TH; Steurer J; Holm A; Gonzales R; Dinant GJ; de Groot JA; Verheij TJ
    PLoS One; 2016; 11(2):e0149895. PubMed ID: 26918859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Personalisation of breast cancer follow-up: a time-dependent prognostic nomogram for the estimation of annual risk of locoregional recurrence in early breast cancer patients.
    Witteveen A; Vliegen IM; Sonke GS; Klaase JM; IJzerman MJ; Siesling S
    Breast Cancer Res Treat; 2015 Aug; 152(3):627-36. PubMed ID: 26162567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a new predictive model for breast cancer survival in New Zealand and comparison to the Nottingham prognostic index.
    Elwood JM; Tawfiq E; TinTin S; Marshall RJ; Phung TM; Campbell I; Harvey V; Lawrenson R
    BMC Cancer; 2018 Sep; 18(1):897. PubMed ID: 30223800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Dutch Prediction Tool to Assess the Risk of Additional Axillary Non-Sentinel Lymph Node Involvement in Sentinel Node-Positive Breast Cancer Patients.
    van den Hoven I; van Klaveren D; Voogd AC; Vergouwe Y; Tjan-Heijnen V; Roumen RM
    Clin Breast Cancer; 2016 Apr; 16(2):123-30. PubMed ID: 26602438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Logistic Regression and Bayesian Networks for Risk Prediction of Breast Cancer Recurrence.
    Witteveen A; Nane GF; Vliegen IMH; Siesling S; IJzerman MJ
    Med Decis Making; 2018 Oct; 38(7):822-833. PubMed ID: 30132386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.